Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $22,044 - $48,648
600 New
600 $47,000
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $7,698 - $10,249
-297 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$21.63 - $40.07 $27,059 - $50,127
-1,251 Reduced 80.81%
297 $10,000
Q1 2021

May 17, 2021

BUY
$17.75 - $47.82 $26,305 - $70,869
1,482 Added 2245.45%
1,548 $64,000
Q4 2020

Feb 16, 2021

BUY
$11.91 - $19.9 $786 - $1,313
66 New
66 $1,000
Q3 2020

Nov 16, 2020

SELL
$13.78 - $18.84 $10,624 - $14,525
-771 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$11.66 - $18.26 $8,989 - $14,078
771 New
771 $14,000
Q3 2019

Nov 14, 2019

SELL
$20.27 - $28.93 $324 - $462
-16 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.36 - $30.41 $357 - $486
16 New
16 $0

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.29B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.